NCT01914939: An overdue trial by Massachusetts General Hospital
This trial is overdue. It was due to report 1 year, 2 months ago.
- We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
- Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
- Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.
|Full entry on ClinicalTrials.gov||NCT01914939|
|Title||A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder|
|ACT or pACT?||This is what FDAAA officially calls a "probable Applicable Clinical Trial"|
|Start date||April 30, 2014|
|Completion date||Nov. 30, 2017|
|Required reporting date||Nov. 30, 2018, midnight|
|Actual reporting date||None|
|Date last checked at ClinicalTrials.gov||Feb. 20, 2020|